TP53 and colorectal cancer: In fact, the survival for patients with colorectal cancers expressing mutated p53, has been shown to be significantly worse than for those patients with tumours that expressed the wild-type protein and this was most striking when mutations occurred outside the evolutionarily conserved regions [38], [39].